2018 American Transplant Congress

June 2-6, 2018 in Seattle, WA

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Can We Expect the “Unexpected”?

D. Pinelli, A. Tambur.
Can We Optimise Immunosuppression Strategies in Our Older Renal Transplant Recipients?

M. Morton,¹ K. Parker,¹ C. Morecroft.²
Cancer Incidence after Kidney Transplantation in Saudi Arabia, Comparing Different Induction Agents

H. AlEid, S. Raza, T. Ali, I. Alahmadi, S. Aleid, D. Broering.
Cannabis Dependence or Abuse before and after Kidney Transplantation: Implications for Post-Transplant Outcomes

K. Lentine,¹ T. Alhamad,² N. Lam,³ A. Naik,⁴ F. Koraishy,¹ H. Randall,¹ D. Segev,⁵ V. Dharnidharka,² D. Brennan,⁵ B. Kasiske,⁶ R. Ouseph,¹ M. Schnitzler.¹
Cannabis Use in Liver Transplant Recipients: A Single Center Experience

J. Lee, M. Valadez, E. Moreno, D. Markovic, V. Agopian, J. DiNorcia, H. Yersiz, D. Farmer, R. Busuttil, F. Kaldas.
Cardiac Grafts from Insulin Resistant Donors Trigger a Heightened Immune Response via Excessive Induction of Autophagy

S. Cai,¹ J. Miao,² A. Chandraker.¹
Cardiac MRI May Help to Determine When to Refer Heart Transplant Patients for Redo Heart Transplant

M. Kittleson, J. Patel, E. Kransdorf, S. Dimbil, R. Levine, D. Geft, D. Chang, L. Czer, J. Kobashigawa.
Cardiovascular Risk and Subclinical Vascular Damage in Patients after Pediatric Liver Transplantation

H. Wilke,¹ N. Memaran,¹ I. Goldschmidt,¹ B. Borchert-Mörlins,¹ A. von Wick,¹ E. Bauer,¹ R. Blöte,¹ B. Schmidt,² A. Melk.¹
Carfilzomib and Belatacept Reduces DSA and Prolongs Survival in a Highly Sensitized Rhesus Model of Kidney Transplantation

B. Ezekian, J. Kwun, P. Schroder, M. Manook, J. Yoon, M. Mulvihill, K. Freischlag, J. Cochran, K. Kroning, J. Yi, S. Knechtle.
Cause of ESRD is Not Associated with Risk of Post-Transplant CMV Infection

S. Panzer, S. Peery, B. Astor, A. Djamali, T. Singh.

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z